Mangalam Drugs & Organics
25.40
+1.13(+4.66%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+4.66%
1M-61.43%
6M-69.18%
1Y-79.06%
5Y-82.22%
View Company Insightsright
More news about Mangalam Drugs & Organics
06Sept 25
Mangalam Drugs Shares Pledged by Shree Kishoriju Trading for Debt Security
Shree Kishoriju Trading and Investment Private Limited has pledged 877,000 shares (5.54%) of Mangalam Drugs & Organics Limited to Badjate Stock Broking Private Limited. This increases Shree Kishoriju's total encumbered holdings to 1,098,515 shares, representing 6.94% of the company's share capital. Director Radhika Ajay Dhoot disclosed this information to stock exchanges in compliance with regulations.
14Aug 25
Mangalam Drugs & Organics' Merger Scheme Receives Strong Backing from Unsecured Creditors
Mangalam Drugs & Organics Limited's proposed merger scheme gained overwhelming support from unsecured creditors at a Tribunal Convened Meeting. The scheme, involving the absorption of Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited, received 98.46% approval in value terms. Out of 80 eligible creditors, 36 participated, with 37 voting in favor and 1 against. The Board of Directors is now authorized to proceed with implementing the merger, subject to regulatory approvals.
Mangalam Drugs & Organics
25.40
+1.13
(+4.66%)
1 Year Returns:-79.06%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)